Dose uniformity of topical corticosteroid preparations: difluprednate ophthalmic emulsion 0.05% versus branded and generic prednisolone acetate ophthalmic suspension 1%
William Stringer1, Roy Bryant21Module 3 Pharma Services, St. Petersburg, Florida; 2Encompass Pharmaceutical Services, Norcross, Georgia, USAPurpose: To compare the dose uniformity of difluprednate ophthalmic emulsion 0.05% (Durezol®) with both branded and generic prednisolone acetate oph...
Enregistré dans:
Auteurs principaux: | William Stringer, Roy Bryant |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Dove Medical Press
2010
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/8b37c7a0aa594e8e87db1d64a3326f62 |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Dose uniformity of loteprednol etabonate ophthalmic gel (0.5%) compared with branded and generic prednisolone acetate ophthalmic suspension (1%)
par: Marlowe ZT, et autres
Publié: (2013) -
Difluprednate 0.05% versus Prednisolone Acetate Post-Phacoemulsification for Inflammation and Pain: An Efficacy and Safety Clinical Trial
par: Palacio-Pastrana C, et autres
Publié: (2020) -
Localized alopecia and suppression of hypothalamic-pituitary-adrenal (HPA) axis in dogs following treatment with difluprednate 0.05% ophthalmic emulsion (Durezol®)
par: Katelin Quantz, et autres
Publié: (2021) -
The role of difluprednate ophthalmic emulsion in clinical practice
par: Karim N Jamal, et autres
Publié: (2009) -
Difluprednate ophthalmic emulsion 0.05% (Durezol®) administered two times daily for managing ocular inflammation and pain following cataract surgery
par: Stephen Smith, et autres
Publié: (2010)